A Long-term Safety Surveillance Study in Participants Previously Treated With 177Lu-IPN01072
NCT05017662
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
OTHER:
Data collection
Sponsor
Ariceum Therapeutics GmbH